Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06000033
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-21
First Post:
2023-08-14
Brief Title:
Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative HER2-Low-Expressing Metastatic Breast Cancer
Sponsor:
Organization:
Qilu Hospital of Shandong University